Avenir Wellness Solutions, Inc. (OTCPK: AVRW)
Health Care · Pharmaceuticals · US
$0.00
+100.00% today · +100.0% 1Y
Avenir Wellness Solutions, Inc. (OTCPK: AVRW) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $18.04K and employs 11 people.
Over the last twelve months the share price has gained 100.0%, trading between 0.00 and 0.25.
Tweenvest scores Avenir Wellness Solutions, Inc. across four factors: quality 10/100, value 46/100, growth 72/100. Its strongest factor is growth.
AVRW price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $18.04K
- Revenue (TTM)
- $2.04M
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- 88.98
- 52-week high
- $0.25
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 90.20M
- Employees
- 11
- Next earnings
- —
About Avenir Wellness Solutions, Inc.
Avenir Wellness Solutions, Inc., operating through its subsidiary The Sera Labs, Inc., specializes in crafting advanced nutraceutical formulations and innovative delivery technologies. Their objective is to maximize product effectiveness and enhance overall well-being. The company offers a diverse range of products across the beauty, health and wellness, and pet care segments, sold under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brands. Distribution channels include major drugstores, supermarkets, convenience stores, and mass retailers. Additionally, Avenir Wellness Solutions supplies products under private labels to other retailers and multi-level marketing firms, and directly to consumers online, including through subscription services. Established in 2014, the company was formerly known as CURE Pharmaceutical Holding Corp. before adopting its current name in October 2022. Its corporate headquarters are located in Sherman Oaks, California.
- ISIN
- US23127P1049
- Founded
- 2014
- Listed since
- Feb 3, 2017
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.